Among the 8 genes in the IRS model, SYT12 is reported to play a vital role in oral squamous cell carcinoma (OSCC) progression via CAMK2N1 and could be a new target for OSCC patients [38]. This evidence concerns the gene SYT12 and oral cavity squamous cell carcinoma.